Richard W. Pascoe
Equibles does not estimate personal net worth.
Get an email with a short summary when Zevra Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ZVRA alertsAbout Richard W. Pascoe
Richard W. Pascoe is recorded as CEO at Zevra Therapeutics, Inc. (ZVRA) since January 6, 2023. Zevra Therapeutics, Inc. reported in an 8-K filed May 15, 2023 that Richard W. Pascoe resigned as Chief Executive Officer, effective June 1, 2023. Zevra Therapeutics, Inc. reported in an 8-K filed May 8, 2023 that Richard W. Pascoe resigned as Chief Executive Officer, effective June 1, 2023. Zevra Therapeutics, Inc. reported in an 8-K filed January 9, 2023 that Richard W. Pascoe resigned as Executive Chairman, effective January 6, 2023. Equibles holds 4 filed executive changes naming Richard W. Pascoe; each is listed under recent activity with its source filing. The proxy statement of Zevra Therapeutics, Inc. reports total compensation of $4,122,558 for Richard W. Pascoe in fiscal 2023, including a base salary of $273,576. Disclosed compensation is on record for 3 fiscal years. Zevra Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zevra Therapeutics, Inc. includes Christal M.M. Mickle (CEO), Neil F. McFarlane (CEO and Board Member), Matthew R. Plooster (Chairman) and 7 others.
“As previously reported, Richard W. Pascoe resigned as Zevra’s Chief Executive Officer, effective as of the Effective Date.”
“On May 5, 2023, Richard W. Pascoe, the Chief Executive Officer of Zevra Therapeutics, Inc. (the "Company" or "Zevra"), resigned as the Company's Chief Executive Officer, effective as of June 1, 2023.”
Affiliation history
-
Current
2023-01-06–present
-
2023-01-06–2023-06-01
-
Start not stated–2023-01-06
Company network
Leadership on record at Zevra Therapeutics, Inc.
- Christal M.M. Mickle CEO
- Neil F. McFarlane CEO, Board Member
- Matthew R. Plooster Chairman
- Richard Pascoe Chairman
- Tamara A. Favorito Chairman
- Timothy Sangiovanni CFO
- Alicia Secor Board Member
- Alvin Shih, M.D. Board Member
- Christopher A. Posner Board Member
- Corey Watton Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Zevra Therapeutics, Inc. (ZVRA) | Former Chief Executive Officer and Director | $273,576 | $4,122,558 |
| 2022 | Zevra Therapeutics, Inc. (ZVRA) | Former Chief Executive Officer and Director | $422,917 | $1,360,976 |
| 2021 | Zevra Therapeutics, Inc. (ZVRA) | Executive chairman | $119,814 | $712,482 |